Evidence map›Paper›PMID 38239072›Full record

ArticleClinical and translational medicine2024

Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis.

Carmen González-Olmedo, Francisco José García-Verdejo, Antonio Reguera-Teba, Carmen Rosa-Garrido, José Antonio López-López, Leticia Díaz-Beltrán, Patricia Mena García, Natalia Luque-Caro, Fernando Gálvez-Montosa, Ana Laura Ortega-Granados and 9 more

Abstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Carmen González-OlmedoMedical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Francisco José García-VerdejoMedical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Antonio Reguera-TebaDepartment of General Surgery, University Hospital of Jaén, Jaén, Andalucia, Spain.
Carmen Rosa-GarridoFundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero, University Hospital of Jaén, Jaén, Spain.
José Antonio López-LópezMedical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Leticia Díaz-BeltránMedical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Patricia Mena GarcíaFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain.
Natalia Luque-CaroMedical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Fernando Gálvez-MontosaMedical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Ana Laura Ortega-GranadosMedical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
María Ruiz-SanjuanMedical Oncology Unit, University Hospital of Jaén, Jaén, Spain.
Antonio Cózar-IbáñezDepartment of General Surgery, University Hospital of Jaén, Jaén, Andalucia, Spain.
Juan SainzGenomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS, Granada, Spain.
Juan Antonio MarchalInstituto de Investigación Biosanataria IBs.Granada, Granada, Spain.ORCID 0000-0002-4996-8261
José CamachoExcellence Research Unit "Modeling Nature" (MNat), University of Granada, Granada, Spain.
José Pérez Del PalacioFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain.
Rosario Fernández-GodinoFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain.
Caridad DíazFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Armilla, Granada, Spain.ORCID 0000-0003-1240-0143
Pedro Sánchez-RoviraMedical Oncology Unit, University Hospital of Jaén, Jaén, Spain.

Funding

Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental Alejandro Otero (FIBAO)MERCK
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsLiver NeoplasmsHumansOxaliplatinOxaliplatin

Identifiers

PMID38239072
PMCPMC10797245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.